Neuro-Oncology Reviews




Volume 28 Number 13
10 May 2026




Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 13, 10 May






Khaliq HMH.
Tumour Microenvironment in Brain Cancer: A Neural Niche or a Hijacked Memory System?
J Coll Physicians Surg Pak. 2026 May;36(5):569-570. doi: 10.29271/jcpsp.2026.05.569. PMID: 42152192. ˍ




Pinzón-Ramírez V, Cueva-Cañola LE, Natera DE, Olivera HEA, Camacho-Hernández OE, Beltran-De la Fuente AC, Ramirez-Alvarez SA, Cubas EYG, Flores GV, Gamez ME, Castilla LR.
Clinical outcomes of adding vincristine to procarbazine-lomustine in patients with gliomas: insights from current evidence.
Ecancermedicalscience. 2026 May 1;20:2115. doi: 10.3332/ecancer.2026.2115. PMID: 42416239. ˍ




Arjeini Y, Khalili Dermani S, Sadeh S, Abdolalipour E, Saberpour M, Zargaran H, Mohebbi SR, Ghaemi A.
Oncolytic viruses in brain cancer therapy: advances, challenges, and clinical trial outcomes.
Immunotherapy. 2026 May 4;18(3):249-270. doi: 10.1080/1750743X.2026.2640755. PMID: 42077101˰ ˍ




Halac E, Begagic E, Pojskic M, Arnautovic K.
Treatment Strategies and Outcomes for Spinal Low-grade Gliomas: A Systematic Review of the Past Quarter Century.
Neurosurg Clin N Am. 2026 May 6;37(3):331-351. doi: 10.1016/j.nec.2026.03.008. PMID: 42264663˰ ˍ




Abuliezi N, Sun Y, Zhao J, Qu X, Wu Y, Liao T, Kuerban G, Dun X, Wu Q.
Efficacy and safety of tumor treating fields (TTF) combined with chemotherapy versus chemotherapy only in the treatment of glioblastoma: a systematic review and meta-analysis.
Front Med (Lausanne). 2026 May 8;13:1812119. doi: 10.3389/fmed.2026.1812119. PMID: 42180742. ˍ




Dvir R, Elhasid R, Roth J, Constantini S, Peled Y, Ospovat I, Shiran SI.
Pediatric metastatic medulloblastoma: upfront biopsy followed by oncological treatment without excision of the primary tumor.
J Neurosurg Pediatr. 2026 May 8:1-8. doi: 10.3171/2025.12.PEDS25467. PMID: 42102399. ˍ




Leeper HE, Oliver K, Bulbeck H, Johnson MO.
Translating Cancer Science Into Cancer Care: Using Serious Illness Communication Frameworks to Deliver High-Quality Person-Centered Care in Neuro-Oncology.
Am Soc Clin Oncol Educ Book. 2026 May 8;46(3):e525426. doi: 10.1200/EDBK-26-525426. PMID: 42102343. ˍ




Sung JY, Hwang K.
Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistance.
Mol Biomed. 2026 May 8;7(1):63. doi: 10.1186/s43556-026-00467-8. PMID: 42101535. ˍ




Welch RL, Moziak K, Zang X, Martin AM.
Immune checkpoint inhibitors in medulloblastoma: current updates in preclinical and clinical developments.
Front Oncol. 2026 May 8;16:1725230. doi: 10.3389/fonc.2026.1725230. PMID: 42180054. ˍ